Rapid, convenient and efficient kit-independent detection of SARS-CoV-2 RNA.


Journal

Journal of virological methods
ISSN: 1879-0984
Titre abrégé: J Virol Methods
Pays: Netherlands
ID NLM: 8005839

Informations de publication

Date de publication:
12 2020
Historique:
received: 13 05 2020
revised: 28 08 2020
accepted: 30 08 2020
pubmed: 7 9 2020
medline: 1 12 2020
entrez: 6 9 2020
Statut: ppublish

Résumé

Pandemic SARS-CoV-2 infection has rapidly developed into a socioeconomic and humanitarian catastrophe. Basic principles to prevent SARS-CoV-2 transmission are social distancing, face masks, contact tracing and early detection of SARS-CoV-2. To meet these requirements, virtually unlimited test capacities delivering results in a rapid and reliable manner are a prerequisite. Here, we provide and validate such a rapid, convenient and efficient kit-independent detection of SARS-CoV-2 RNA, termed COVID-quick-DET. This straightforward method operates with simple proteinase K treatment and repetitive heating steps with a sensitivity of 94.6% in head-to-head comparisons with kit-based isolation methods. This result is supported by data obtained from serially diluted SARS-CoV-2 virus stocks. Given its cost- and time-effective operation, COVID-quick-DET might be best suited for countries with general shortage or temporary acute scarcity of resources and equipment.

Identifiants

pubmed: 32891677
pii: S0166-0934(20)30217-2
doi: 10.1016/j.jviromet.2020.113965
pmc: PMC7468345
pii:
doi:

Substances chimiques

RNA, Viral 0
Reagent Kits, Diagnostic 0
Endopeptidase K EC 3.4.21.64

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113965

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Références

Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
PLoS One. 2021 Mar 31;16(3):e0247614
pubmed: 33788852
Sci Rep. 2018 Oct 5;8(1):14858
pubmed: 30291287
J Virol Methods. 2004 Oct;121(1):85-91
pubmed: 15350737
Dermatology. 2006;212 Suppl 1:119-23
pubmed: 16490989
Clin Chem. 2020 Apr 1;66(4):549-555
pubmed: 32031583
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930

Auteurs

Detlef Michel (D)

Institute for Virology, University Hospital Ulm, Ulm, Germany.

Karin M Danzer (KM)

Department of Neurology, Ulm University, Ulm, Germany. Electronic address: karin.danzer@uni-ulm.de.

Rüdiger Groß (R)

Institute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany.

Carina Conzelmann (C)

Institute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany.

Janis A Müller (JA)

Institute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany.

Axel Freischmidt (A)

Department of Neurology, Ulm University, Ulm, Germany.

Jochen H Weishaupt (JH)

Department of Neurology, Ulm University, Ulm, Germany.

Sandra Heller (S)

Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.

Jan Münch (J)

Institute of Molecular Virology, Ulm University Medical Centre, Ulm, Germany.

Manuela Michel (M)

Institute for Virology, University Hospital Ulm, Ulm, Germany.

Thomas Stamminger (T)

Institute for Virology, University Hospital Ulm, Ulm, Germany.

Alexander Kleger (A)

Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany. Electronic address: alexander.kleger@uni-ulm.de.

Markus Otto (M)

Department of Neurology, Ulm University, Ulm, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH